Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Ehrhardt

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Plos One|May 10, 2012
RNA interference is responsible for reduction of transgene expression after Sleeping Beauty transposase mediated somatic integrationChristina Rauschhuber, Anja Ehrhardt
Current Gene Therapy|November 1, 2007
Emerging adenoviral vectors for stable correction of genetic disordersLorenz Jager, Anja Ehrhardt
Virus Genes|September 19, 2017
From Virus to vector to medicine: Foreword by guest editorsFlorian Kreppel, Anja Ehrhardt
Virus Genes|July 17, 2017
Getting genetic access to natural adenovirus genomes to explore vector diversityWenli Zhang, Anja Ehrhardt
Human Gene Therapy|April 15, 2009
Persistence of high-capacity adenoviral vectors as replication-defective monomeric genomes in vitro and in murine liverLorenz Jager, Anja Ehrhardt
Blood|May 16, 2002
A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivoAnja Ehrhardt, Mark A Kay
Viruses|October 14, 2011
Viral hybrid vectors for somatic integration - are they the better solution?Nadine Müther, Nadja Noske, Anja Ehrhardt
European Journal of Cell Biology|March 29, 2011
New insights into stability of recombinant adenovirus vector genomes in mammalian cellsChristina Rauschhuber, Nadja Noske, Anja Ehrhardt
Cancers|May 7, 2020
Expanding the Spectrum of Adenoviral Vectors for Cancer TherapyJian Gao, Wenli Zhang, Anja Ehrhardt
Human Gene Therapy Methods|May 15, 2018
Novel Vector Construction Based on Alternative Adenovirus Types via Homologous RecombinationWenli Zhang, Jun Fu, Anja Ehrhardt
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Plos One|May 10, 2012
RNA interference is responsible for reduction of transgene expression after Sleeping Beauty transposase mediated somatic integrationChristina Rauschhuber, Anja Ehrhardt
Current Gene Therapy|November 1, 2007
Emerging adenoviral vectors for stable correction of genetic disordersLorenz Jager, Anja Ehrhardt
Virus Genes|September 19, 2017
From Virus to vector to medicine: Foreword by guest editorsFlorian Kreppel, Anja Ehrhardt
Virus Genes|July 17, 2017
Getting genetic access to natural adenovirus genomes to explore vector diversityWenli Zhang, Anja Ehrhardt
Human Gene Therapy|April 15, 2009
Persistence of high-capacity adenoviral vectors as replication-defective monomeric genomes in vitro and in murine liverLorenz Jager, Anja Ehrhardt
Blood|May 16, 2002
A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivoAnja Ehrhardt, Mark A Kay
Viruses|October 14, 2011
Viral hybrid vectors for somatic integration - are they the better solution?Nadine Müther, Nadja Noske, Anja Ehrhardt
European Journal of Cell Biology|March 29, 2011
New insights into stability of recombinant adenovirus vector genomes in mammalian cellsChristina Rauschhuber, Nadja Noske, Anja Ehrhardt
Cancers|May 7, 2020
Expanding the Spectrum of Adenoviral Vectors for Cancer TherapyJian Gao, Wenli Zhang, Anja Ehrhardt
Human Gene Therapy Methods|May 15, 2018
Novel Vector Construction Based on Alternative Adenovirus Types via Homologous RecombinationWenli Zhang, Jun Fu, Anja Ehrhardt
Pageof 13